BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of $11.13 billion as of October 29, 2026. It is the 2,009th most valuable company in the world and the 726th biggest in the United States. Its market cap has increased by 8.29% in one year.

Market Cap

11.13B

Enterprise Value

14.46B

1-Year Change

8.29%

Global Rank

#2,009

Country Rank

#726 United States

ChartMarket Cap Chart

Chart

Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $11.13B, an increase of 2,409.82%. That is a compound annual growth rate of 12.54%.

Market Cap History

Date	Market Cap	% Change
Oct 29, 2026	11.13B	-2.53%
Dec 31, 2025	11.42B	-8.86%
Dec 31, 2024	12.53B	-31.03%
Dec 29, 2023	18.16B	-5.57%
Dec 30, 2022	19.23B	18.58%
Dec 31, 2021	16.22B	1.90%
Dec 31, 2020	15.92B	4.81%
Dec 31, 2019	15.19B	0.17%
Dec 31, 2018	15.16B	-3.18%
Dec 29, 2017	15.66B	9.92%
Dec 30, 2016	14.25B	-15.66%
Dec 31, 2015	16.89B	26.72%
Dec 31, 2014	13.33B	33.25%
Dec 31, 2013	10.00B	64.58%
Dec 31, 2012	6.08B	54.81%
Dec 30, 2011	3.93B	42.26%
Dec 31, 2010	2.76B	45.68%
Dec 31, 2009	1.89B	6.63%
Dec 31, 2008	1.78B	-48.15%
Dec 31, 2007	3.43B	128.90%
Dec 29, 2006	1.50B	87.98%
Dec 30, 2005	796.50M	93.28%
Dec 31, 2004	412.10M	-16.92%
Dec 31, 2003	496.00M	31.08%
Dec 31, 2002	378.40M	-36.33%

View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Summit Therapeutics	12.61B
Bio-Techne	11.40B
Twist Bioscience	10.88B
Kymera Therapeutics	10.19B
Caris Life Sciences	10.02B
Madrigal Pharmaceuticals	9.96B
Vaxcyte	9.67B
Krystal Biotech	9.51B

Market Cap Rankings